Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-04-27 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.370 | -1.040 | -0.6700 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
TSHA | Taysha Gene Therapies | 24.96 | -0.61 | -2.39% | 965.6M |
You can purchase shares of Taysha Gene Therapies (NASDAQ: TSHA) through any online brokerage.
Other companies in Taysha Gene Therapies’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Syndax Pharmaceuticals (NASDAQ:SNDX) and Humanigen (NASDAQ:HGEN).
The latest price target for Taysha Gene Therapies (NASDAQ: TSHA) was reported by Chardan Capital on 2021-04-13. The analyst firm set a price target for 67.50 expecting TSHA to rise to within 12 months (a possible 163.98% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $25.57 last updated Today at 8:00:02 PM.
There are no upcoming dividends for Taysha Gene Therapies.
There is no upcoming split for Taysha Gene Therapies.